Huateng Pharmaceutical, a global supplier of pharmaceutical intermediates, offers Larotrectinib intermediates  (R)-2-(2,5-difluorophenyl)pyrrolidine (R)-2-hydroxysuccinate (CAS No.: 1919868-77-1) for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation.

Larotrectinib (tradename Vitrakvi) is a drug for the treatment of cancer. It is an inhibitor of tropomyosin kinase receptors TrkA, TrkB, and TrkC.

Find More Larotrectinib Intermediates>>>